Teva Clouds Potential ‘Mylan-Perrigo World’ With ‘Uncertainty’
This article was originally published in The Tan Sheet
Executive Summary
Teva’s pursuit of Mylan has the most influence on whether Mylan could make Perrigo an acceptable offer, Perrigo head Joseph Papa tells analysts. Mylan, meanwhile, says it filed a notification with Ireland’s securities regulator to begin the process of submitting its offer to Perrigo’s shareholders.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.